Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.
J Allergy Clin Immunol
; 154(4): 882-892, 2024 Oct.
Article
in En
| MEDLINE
| ID: mdl-39111348
ABSTRACT
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research as well as debates on the mechanisms and management of eosinophilic gastrointestinal diseases. Updates on recent clinical trials and consensus guidelines were also presented. We summarize the updates on eosinophilic gastrointestinal diseases presented at the symposium.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Enteritis
/
Eosinophilia
/
Gastritis
Limits:
Animals
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2024
Document type:
Article
Country of publication:
United States